Exfoliation syndrome (XFS) is a common condition that causes high-tension open-angle glaucoma (XFG), pre- mature cataract formation, and complications during cataract surgery. Evidence suggests that XFS/XFG is genetically complex. LOXL1 is a major genetic risk factor for XFS/XFG, with LOXL1 variants occurring in up to 98% of patients. However, these same variants are also present in up to 80% of unaffected individuals, indicating that additional genetic and/or environmental factors are necessary for disease development. Our goal is to comprehensively define risk factors (both genetic and environmental) for XFS/XFG, which will facilitate effective screening and prevention strategies and the development of novel therapies. In the previous funding period, using data from large ongoing prospective cohorts of Nurses' Health Study (NHS) and Health Professionals Follow-up Study (HPFS), we have identified major environmental exposures significantly influencing the risk of XFS/XFG including time spent outdoors, heavy coffee consumption and low dietary folate intake (related to elevated homocysteine). Using a case control sample from Mass Eye and Ear, we have assessed the contributions of CLU variants to XFS/XFG and have contributed to an international study identifying CACNA1A as a novel genetic risk factor. From 7 different US sites, we have collected DNA samples for 1241 XFS/XFG cases and genome-wide genotyping for both common and rare SNPs has been completed at CIDR. In NHS and HPFS, we project to have incident 600 cases of XFS/XFG among 100,000+ participants followed prospectively for 30+ years. For the next funding period, we propose the following specific aims: 1) complete genetic analyses to identify new genetic risk factors for XFS/XFG, including contributions of rare variants and explore complex genetic interactions; 2) investigate the role of environmental exposures related to homocysteine (DASH dietary pattern) and UV light exposure and explore interactions with LOXL1, and 3) complete the first pre-diagnostic metabolomic analysis for XFS/XFG focusing on metabolites related to homocysteine and folate and interactions for individual metabolites with LOXL1. This proposed research is significant because it is expected to advance and expand our understanding of the genetic etiology of XFS/XFG as it will leverage data from a large case/control study for genetic analyses and will be the first study of copy number variants and rare variants for this condition. The project is innovative in using prospectively collected environmental exposure data and pre-diagnostic serum for metabolomic studies in NHS/HPFS, to investigate factors present in cases prior to disease development. Overall these studies will advance our understanding of the predispoing events that could be therapeutic targets and biomarkers of disease risk.

Public Health Relevance

Exfoliation syndrome (XFS) and the related glaucoma (XFG) is a leading cause of blindness world-wide. The etiology of XFS/XFG is poorly understood and effective means of primary prevention and curative therapies are not available. In this proposal, our collaborative group will complete studies to identify risk factors for XFS/XFG with the ultimate goal of developing effective screening and prevention strategies and novel therapies targeted to the molecular events responsible for the disease.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY020928-09
Application #
10013224
Study Section
Diseases and Pathophysiology of the Visual System Study Section (DPVS)
Program Officer
Agarwal, Neeraj
Project Start
2011-09-01
Project End
2021-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
9
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts Eye and Ear Infirmary
Department
Type
DUNS #
073825945
City
Boston
State
MA
Country
United States
Zip Code
02114
Pasquale, Louis R; Kang, Jae Hee; Fan, BaoJian et al. (2018) LOXL1 Polymorphisms: Genetic Biomarkers that Presage Environmental Determinants of Exfoliation Syndrome. J Glaucoma 27 Suppl 1:S20-S23
Cousins, C C; Kang, J H; Bovee, C et al. (2017) Nailfold capillary morphology in exfoliation syndrome. Eye (Lond) 31:698-707
Aung, Tin (see original citation for additional authors) (2017) Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet 49:993-1004
Wiggs, Janey L; Pasquale, Louis R (2017) Genetics of glaucoma. Hum Mol Genet 26:R21-R27
Igo Jr, Robert P; Cooke Bailey, Jessica N; Romm, Jane et al. (2016) Quality Control for the Illumina HumanExome BeadChip. Curr Protoc Hum Genet 90:2.14.1-2.14.16
Kang, Jae H; Wu, Juan; Cho, Eunyoung et al. (2016) Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma. Am J Public Health 106:1684-9
Dewundara, Samantha; Pasquale, Louis R (2015) Exfoliation syndrome: a disease with an environmental component. Curr Opin Ophthalmol 26:78-81
Aung, Tin; Ozaki, Mineo; Mizoguchi, Takanori et al. (2015) A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome. Nat Genet 47:387-92
Fan, Bao J; Pasquale, Louis R; Kang, Jae H et al. (2015) Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis. Exp Eye Res 139:115-22
Lee, Richard K (2014) New genetic and proteomic discoveries and recent insights into the risk factors and pathophysiology of how pseudoexfoliation glaucoma develops. Preface. Int Ophthalmol Clin 54:vii-viii

Showing the most recent 10 out of 25 publications